Peptide Compass · Research
GHK-Cu copper peptide: topical research, safety and evidence
GHK-Cu appears in skincare discussions and research-product listings. Those settings need different evidence. Here is what the cited human studies measured, what remains uncertain and how to inspect a supplier’s documents.
What is GHK-Cu?
GHK is the tripeptide glycyl-histidyl-lysine. GHK-Cu refers to its copper complex. Copper-free GHK, GHK-Cu and other modified peptides should not be treated as interchangeable ingredients.
2026 review: chemical identity and evidence attributionTopical GHK-Cu versus injectable research products
Topical research
A cream or gel is a specific formulation. Its findings apply to the tested formulation and setting, not automatically to every product sharing an ingredient name.
Systemic claims
Skin studies cannot establish the safety or effectiveness of an injected product. A different route changes the question the evidence must answer.
Product identity
Check whether a report measures the peptide, the copper complex or only a broad purity value. Blue colour alone does not authenticate a product.
What do human GHK-Cu studies show?
In a 2006 randomised study after CO2 laser resurfacing, 13 participants completed follow-up. The groups did not differ significantly on the objective redness, wrinkle or overall skin-quality measures. Patient-reported satisfaction was higher in the GHK-Cu group. Subjective satisfaction and objective measurements should therefore be reported separately.
Miller et al. (2006): randomised studyA 2026 evidence-mapping review describes limited, heterogeneous clinical evidence and problems comparing formulations. It distinguishes the biological findings from the question of what chemical form was actually delivered. This is a reason to inspect the original studies rather than generalise from an ingredient name.
2026 evidence-mapping reviewA registered topical trial is not a published result
On 1 November 2026, ClinicalTrials.gov listed NCT07437586, a phase 2 study of topical GHK-Cu gel for acute skin wounds, as recruiting. No results were posted. The record’s last posted update was 27 February 2026. These are registry observations, not confirmation of efficacy or actual recruitment progress.
ClinicalTrials.gov: NCT07437586GHK-Cu side effects and safety limits
The evidence discussed here cannot establish a reliable safety profile for injected research products. A lack of reported problems in a small topical study would not exclude uncommon reactions or longer-term risks, and would not validate another formulation.
A laboratory certificate answers selected analytical questions. Identity and purity results do not establish clinical safety, sterility or the absence of endotoxins unless those specific tests were performed and documented.
Documented prices
Prices are recorded snapshots. Each entry states its date, currency and pack variant. Shipping, tax treatment, discount conditions and availability must be rechecked in the shop. A low price is not evidence of quality.
List prices excluding shipping and discounts. Currency and product variants must be compared separately. Availability and delivered batch have not been verified.
| Vendor | Pack | List price | Price/mg | Recorded | Source |
|---|---|---|---|---|---|
| DN Lab Research | 30 mg | 116 EUR | 3.87 EUR/mg | 2026-09-15 | Product page · Ad |
| ELYVERA (Europeptides) | 50 mg | 24.9 EUR | 0.5 EUR/mg | 2026-09-15 | Product page · Ad |
| Europa-Peptide | 50 mg | 24.9 EUR | 0.5 EUR/mg | 2026-09-15 | Product page · Ad |
| Peptidwerk | 50 mg | 34.95 EUR | 0.7 EUR/mg | 2026-09-15 | Product page · Ad |
| Peak Peptide | 50 mg | 39.9 EUR | 0.8 EUR/mg | 2026-09-15 | Product page · Ad |
| PPX.at | 50 mg | 40 EUR | 0.8 EUR/mg | 2026-09-15 | Product page · Ad |
| Beyond Peptides | 50 mg | 41.83 EUR | 0.84 EUR/mg | 2026-09-15 | Product page · Ad |
| Peptide Labz | 50 mg | 45 EUR | 0.9 EUR/mg | 2026-09-15 | Product page · Ad |
| Smart Peptides | 50 mg | 49.9 EUR | 1.0 EUR/mg | 2026-09-15 | Product page · Ad |
| Driada | 50 mg | 50 EUR | 1.0 EUR/mg | 2026-09-15 | Product page · Ad |
| Particle Peptides | 50 mg | 67.99 EUR | 1.36 EUR/mg | 2026-09-15 | Product page · Ad |
| Peptidwerk | 100 mg | 54.95 EUR | 0.55 EUR/mg | 2026-09-15 | Product page · Ad |
| Bio BoostX | 100 mg | 59.95 EUR | 0.6 EUR/mg | 2026-09-15 | Product page · Ad |
| BioCollex | 50 mg | 40 USD | 0.8 USD/mg | 2026-09-15 | Product page · Ad |
| American Peptides | 50 mg | 50 USD | 1.0 USD/mg | 2026-09-15 | Product page · Ad |
| Protide Health | 50 mg | 55 USD | 1.1 USD/mg | 2026-09-15 | Product page · Ad |
| Chameleon Peptides | 50 mg | 61.2 USD | 1.22 USD/mg | 2026-09-15 | Product page · Ad |
| Licensed Peptides | 50 mg | 61.99 USD | 1.24 USD/mg | 2026-09-15 | Product page · Ad |
| Protide Health | 100 mg | 65 USD | 0.65 USD/mg | 2026-09-15 | Product page · Ad |
Questions about copper peptides
Does GHK-Cu grow hair or reverse skin ageing?
Those claims require evidence for a particular formulation and outcome. The limited, mixed clinical evidence discussed here does not support a blanket promise for GHK-Cu products.
Is GHK-Cu the same as a copper supplement?
No. A peptide-copper complex and a generic copper supplement describe different materials. They should not be substituted on the assumption that copper content makes them equivalent.
Where is the GHK-Cu protocol?
This page explains study designs and evidence limitations. It does not provide preparation instructions, injection advice or a human-use regimen.
Compare the documentation behind a listing
Match the named substance, batch identifier and report method before comparing pack prices. The table retains its historical price dates. No shop product on this page has been tested by Peptide Compass.
Sources and scope
Editorial source check: 1 November 2026. Study summaries refer to the linked publications and registry records, not to a test of any shop product.
Created with AI assistance. This new edition has not yet received independent editorial review.